{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:57:09Z","timestamp":1761292629700},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.radonc.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T08:21:08Z","timestamp":1244794868000},"page":"654","source":"Crossref","is-referenced-by-count":8,"title":["Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer"],"prefix":"10.1016","volume":"93","author":[{"given":"Andrew","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daren","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2009.05.005_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.radonc.2009.05.005_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","article-title":"Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer","volume":"90","author":"Pryor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.05.005_bib3","unstructured":"National Institute for Health and Clinical Excellence. Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck. Final appraisal determination; 30 April 2008."},{"key":"10.1016\/j.radonc.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ijrobp.2006.11.015","article-title":"Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck","volume":"67","author":"Sanghera","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T21:23:32Z","timestamp":1545168212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814009002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0167814009002382"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2009.05.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}